Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Namisol in chronic pancreatitis pain
NL-OMON35767Phase 2Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium oxybate in chronic pancreatitis (CP) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: VAS pain at rest and VAS pain on movement. Started Oct 2011; status: active, not recruiting.
02
Drugs
sodium oxybate
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on NL-OMON35767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35767.